A randomized controlled trial of fish-oil supplementation for children with autism spectrum disorder.

Phase 2

• Conditions: Autism Spectrum Disorders; Mental Health - Autistic spectrum disorders; Alternative and Complementary Medicine - Other alternative and complementary medicine

• Registration Number: ACTRN12613000334707
• Lead Sponsor: Princess Margaret Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-03-26
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Children with a DSM-IV diagnosis of ASD (including Autistic Disorder, Pervasive-Developmental Disorder Not Otherwise Specified (PDD-NOS) and Asperger’s Syndrome)

Exclusion Criteria

1. A fish allergy
2. Are taking medication for other medical conditions (including diabetes, blood pressure)
3. Are currently taking psychotropic medication for the treatment of aggression, tantrums or self-injurious behaviour
4. Have diabetes
5. Have a bleeding disorder
6. Have a seizure disorder
7. Have other serious medical conditions
8. Current or prior ( < 3 months prior to the intervention) use of omega-3 fatty acids.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Total score, and sub-scale scores on the Aberrant Behaviour Checklist (ABC). [Following six months of fish oil or placebo supplementation. ]